Prevalence of medication-related osteonecrosis of the jaw (MRONJ) in breast cancer patients receiving low-dose bone modifying agents for cancer treatment-induced bone loss (CTIBL): need for further data.

Authors

Vittorio Fusco

Published in

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. Volume 34. Issue 7. Jun 24, 2026. Epub Jun 24, 2026.

PMID:
42340461
Bibliographic data and abstract were imported from PubMed on 24 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.